Submitted Successfully!
To reward your contribution, here is a gift for you: A free trial for our video production service.
Thank you for your contribution! You can also upload a video entry or images related to this topic.
Version Summary Created by Modification Content Size Created at Operation
1 -- 2954 2022-07-01 08:50:34 |
2 Format correction Meta information modification 2954 2022-07-01 11:27:32 |

Video Upload Options

Do you have a full video?


Are you sure to Delete?
If you have any further questions, please contact Encyclopedia Editorial Office.
Li, H.;  Guo, R.;  Guan, Y.;  Li, J.;  Wang, Y. Trans-Synaptic Neurexin–Neuroligin Interaction. Encyclopedia. Available online: (accessed on 13 April 2024).
Li H,  Guo R,  Guan Y,  Li J,  Wang Y. Trans-Synaptic Neurexin–Neuroligin Interaction. Encyclopedia. Available at: Accessed April 13, 2024.
Li, Huili, Ruijuan Guo, Yun Guan, Junfa Li, Yun Wang. "Trans-Synaptic Neurexin–Neuroligin Interaction" Encyclopedia, (accessed April 13, 2024).
Li, H.,  Guo, R.,  Guan, Y.,  Li, J., & Wang, Y. (2022, July 01). Trans-Synaptic Neurexin–Neuroligin Interaction. In Encyclopedia.
Li, Huili, et al. "Trans-Synaptic Neurexin–Neuroligin Interaction." Encyclopedia. Web. 01 July, 2022.
Trans-Synaptic Neurexin–Neuroligin Interaction

Synapses serve as the interface for the transmission of information between neurons in the central nervous system. The structural and functional characteristics of synapses are highly dynamic, exhibiting extensive plasticity that is shaped by neural activity and regulated primarily by trans-synaptic cell-adhesion molecules (CAMs). Prototypical trans-synaptic CAMs, such as neurexins (Nrxs) and neuroligins (Nlgs), directly regulate the assembly of presynaptic and postsynaptic molecules, including synaptic vesicles, active zone proteins, and receptors. Therefore, the trans-synaptic adhesion mechanisms mediated by Nrx–Nlg interaction can contribute to a range of synaptopathies in the context of pathological pain and other neurological disorders.

neurexin neuroligin synapse plasticity

1. The Neurexin–Neuroligin Mediated Trans-Synaptic Modulation

1.1. The Dynamic Synaptic Regulation by Neurexins

Early evidence suggested that these Nrxs and their binding partners can modulate synapse numbers and distributions, thereby contributing to the recruitment of pre-and postsynaptic machinery [1][2]. These findings, together with data from recent studies, strongly suggest that Nrxs are key regulators of the overall functionality of synapses, shaping synaptic processes such as transmission and plasticity [1][3].
Several mechanisms govern the roles of Nrxs in organizing diverse synaptic properties. Primarily, Nrxs influence components of the presynaptic machinery and synaptic functional efficiency. For example, Nrx deletion results in the loss of presynaptic active-zone GABARs, decreasing the sensitivity of neurotransmitter release to GABAR activation at both excitatory and inhibitory synapses [4]. Given the importance of presynaptic GABARs in the nucleation of signaling complexes that control the release of neurotransmitters, the ability of Nrxs to regulate these receptors enables them to further govern synaptic transmission and plasticity from the presynaptic perspective [5][6][7]. Additionally, conditional knockout mice deficient for all three β-Nrxs exhibit impaired presynaptic release probability. However, this phenotype is not due to a direct presynaptic effect but is attributed to a trans-synaptic regulatory loop in which presynaptic β-Nrxs regulate postsynaptic tonic endocannabinoid signaling [8].
The critical roles played by Nrxs in the synapse are not limited to presynaptic modulation. Nrxs can also orchestrate postsynaptic properties, thereby shaping the input/output relations of their resident trans-synaptic circuits. For instance, the expression levels of the N-methyl-D-aspartate receptor (NMDAR) and the α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR) are affected by the constitutive inclusion of SS4 in hippocampal presynaptic Nrx-1 and Nrx-3, respectively [9]. Accordingly, conditional control of insertions at Nrx-3 SS4 suppresses the responsivity of glutamate receptor responses mediated by AMPARs, whereas the same manipulation in Nrx-1 enhances NMDAR-mediated glutamate receptor postsynaptic strength. Collectively, these findings suggest an economical molecular mechanism whereby Nrxs and their alternative splicing can contribute to the regulation of AMPAR- and NMDAR-mediated excitatory postsynaptic strength and plasticity [10].
Likewise, GABARs require inhibitory presynaptic terminals for their postsynaptic localization. Specifically, ectopic expression of Nrx-3 in presynaptic neurons could recruit GABARs to postsynaptic sites, thus establishing a trans-synaptic interaction [11]. Consistent with this finding, the Nrx-3 knockout shows altered inhibitory postsynaptic strength, with a pronounced impact on inhibitory postsynaptic current (IPSC) amplitudes in males. In contrast, the same change results in enhanced IPSC amplitudes in females [12]. Moreover, circumstantial evidence indicates that GABAergic synapse specification is influenced by the expression of the highly selective Nrxs SS4 splicing factor sam68-like molecule 2 [13]. These data link the Nrx expression levels and their alternative splicing modulations with the functional regulation of excitatory and inhibitory postsynaptic transmission and plasticity.
Another important mechanism that deserves special attention in relation to Nrxs in synaptic efficiency is the process of proteolytic cleavage. Physiologically, Nrx-1 is cleaved by a disintegrin and metalloproteinase-10 (ADAM-10), resulting in 4–6% of Nrx-1 in the adult brain existing as a soluble ectodomain protein. Blocking ADAM10-mediated Nrx-1 cleavage dramatically increases the synaptic Nrx-1 content, thereby elevating the percentage of excitatory synapses containing Nrx-1 nanoclusters [14]. In fact, the ectodomain cleavage might be critical for the synaptic activity mediated by Nrxs since blocking ectodomain cleavage by metalloproteases reduces β-Nrxs mobility and enhances glutamate release [15]. Moreover, a loss of presenilins that mediate Nrx cleavage induces a drastic accumulation of Nrx C-terminal fragments in cultured rat hippocampal neurons and mouse brains, which coincides with synaptic and memory impairments. These findings suggest that impaired Nrx proteolytic processing may be an early event in the development of dysfunctional synaptic plasticity [16].
Glycosylation of Nrxs may also contribute to their functions in synaptic transmission and plasticity. Nrxs are HS proteoglycans, and the HS component plays a critical role in high-affinity Nrx interaction with Nlgs, LRRTMs, and novel ligands. In line with this notion, reductions in the frequency and amplitude of miniature excitatory postsynaptic currents (EPSCs) recorded from hippocampal neurons have been reported in mice harboring a mutation that interferes with Nrx-1 HS modification, indicating that the HS modification is required for the regulation of synaptic transmission [17]. Given that HS modification of Nrxs is tightly regulated by an activity-dependent mechanism, further research aimed at clarifying how Nrx glycosylation participates in synaptic functional modulation is necessary to shine additional light on this dynamic regulatory process. Overall, the available evidence is consistent with a model in which Nrxs exhibit a high degree of plasticity in the context of synaptic activation, allowing them to shape synaptic transmission and plasticity.

1.2. The Dynamic Synaptic Regulation by Neuroligins

Nlgs aid in organizing and orchestrating several aspects of synaptic function [18]. While early experimental evidence suggests that Nlgs can induce the recruitment of presynaptic specializations in an Nrx-dependent manner, further analyses of mice constitutively lacking Nlg1/2/3 expression suggest that these Nlgs are dispensable in the context of initial synaptic formation [19]. Instead, Nlgs appear to serve as mediators of synaptic transmission and plasticity that are modulated by neural activity, leading to activity-induced synaptic circuit functional reshaping, as emphasized in several recent studies [20].
Firstly, the expression profiles of Nlgs are highly specific, with Nlg-1 localizing mainly to excitatory synapses, Nlg-2 localizing primarily to inhibitory synapses, Nlg-3 localizing to both of these synaptic types, and Nlg-4 localizing primarily to the glycinergic synapses of the retinal system [21]. In agreement with their subcellular distributions, Nlg isoforms contribute differently to the function of glutamatergic vs. GABAergic synapses through their capacity to assemble appropriate scaffolds and functional receptors in the postsynaptic membrane opposing the presynaptic terminals. Specifically, Nlg-1 favors the functional modulation of glutamatergic synapses by recruiting NMDARs via the PSD-95 scaffold proteins and trapping surface-diffusing AMPARs by binding with PSD-95 and stargazin [22]. In contrast, Nlg-2 recruits GABARs or glycine receptors through a specific interaction with gephyrin, driving the functional properties of inhibitory synapses [23]. Thus, Nlgs are confined to excitatory synapses or inhibitory synapses, positioning them to influence the excitation/inhibition ratio, the imbalance of which leads to synaptic dysfunction-associated pathologies (Figure 1A). Indeed, manipulating Nlg expression levels in vitro and in vivo has demonstrated their isoform-specific modulation of synaptic functions. The overexpression of Nlg-1 can specifically enhance AMPAR- and NMDAR-mediated EPSCs in an NMDAR-dependent fashion. In contrast, Nlg-1-knockout mice exhibit reduced NMDAR-mediated EPSC amplitudes and a loss of NMDAR-dependent long-term potential (LTP) [24][25][26]. Of note, NMDAR-dependent LTP is not dependent on the binding of Nlg-1 to PDZ-domain-containing proteins, such as PSD-95. Rather, it requires Nlg-1 binding to Nrxs, as the rescue of LTP by Nlg-1 can be prevented by the mutation of residues critical for Nrx binding. This finding demonstrates the specific and pronounced regulatory role played by Nlg-1 in the context of excitatory synaptic transmission in an Nrx-dependent manner. However, the rescue of basal NMDAR-mediated synaptic transmission after Nlg deletion requires the Nlg-1 intracellular domain but not Nrx binding [27]. This molecular dissociation of Nlg-1 domains required for LTP versus those required for the maintenance of basal NMDAR-mediated synaptic transmission indicates the complexity of the molecular architecture responsible for regulating synaptic strength at excitatory synapses.
Figure 1. Schematic diagram of trans-synaptic interaction between neurexins and neuroligins in normal and pathologic pain. (A) In normal conditions, Nlg-1 and Nlg-2 contribute differently to the function of excitatory and inhibitory transmissions, respectively, in front of corresponding presynaptic Nrxs. Nlg-1 favors the functional modulation of glutamatergic synapses by recruiting NMDARs via the PSD-95 scaffold and trapping surface-diffusing AMPARs by binding with PSD-95 and stargazing. Nlg-2 recruits GABARs or glycine receptors through a specific interaction with gephyrin. The mechanistic importance of Nrx–Nlg is associated with a range of proteins capable of modulating their interaction at the synaptic cleft, in which hevin and SPARC directly interact with Nrx and Nlg, while MDGAs occupy the interaction site between Nrx and Nlg and, thereby, block Nrx–Nlg interaction. (B) In pathologic pain, Nlg-1, as well as the recruitment of corresponding excitatory glutamatergic receptors, is upregulated in the context of pathological pain. Meanwhile, traditionally inhibitory Nlg-2 undergoes a fundamental shift in functionality from inhibition towards excitation, with an increase in co-localization with PSD-95 and subsequent AMPAR subunit targeting under the same condition.
Research on Nlg-2 has fundamentally shaped our understanding of the molecular architecture of Nlg-2 as a central organizer of inhibitory synapses. The protein components of the GABAergic postsynaptic complex, GABARs and gephyrin, are reduced in Nlg-2-knockout mice [23], accompanied by a general reduction in inhibitory synaptic transmission. In contrast, overexpression of Nlg-2 reportedly results in a specific increase in IPSC amplitude, underscoring the role of Nlg-2 as a mediator and regulator of inhibitory synaptic transmission [28][29].
Nlg-3 can either upregulate or downregulate inhibitory synaptic transmission in a splice-variant-dependent manner, suggesting that the specific subcellular localization of the Nlg-3 isoforms may contribute to the functional differences observed between them [30][31]. However, when overexpressed, Nlg-3 enhances excitatory transmission and presynaptic vesicular glutamate transporter 1 expression, irrespective of the Nlg-3 splice variant. Together, these data indicate that alterations in Nlg expression can modulate both excitatory and inhibitory synaptic transmission, thus contributing to synaptic plasticity.
It is also noteworthy that Nlgs function as mediators of synaptic transmission and plasticity in a phosphorylation-dependent manner. For example, calcium/calmodulin-dependent protein kinase II (CaMKII)-mediated phosphorylation of T739 in the Nlg-1 C-terminal domain results in increased surface trafficking, while the mutant protein that could not be phosphorylated leads to reduced Nlg-mediated excitatory synaptic potentiation [32]. Nlg phosphorylation also plays a role in governing postsynaptic protein recruitment, including both surface receptors and scaffold proteins. For instance, protein kinase A can phosphorylate Nlg-1 at S839 and dynamically regulate PSD-95 binding since a phosphomimetic mutation of Nlg-1 at S839 significantly reduces PSD-95 binding [33]. Nevertheless, Nlg-1 phosphorylation at Y782 inhibits gephyrin binding rather than promoting PSD-95 recruitment [34]. Proline-directed Nlg-2 phosphorylation at the S714 residue can ablate gephyrin binding, even though the residue does not fall in the gephyrin-binding domain. A previous study shows that S714 phosphorylation promotes the recruitment of the peptidyl-proly cis-trans isomerase (Pin1) enzyme, which mediates Nlg-2 isomerization and disrupts gephyrin interaction [35].
Nlg phosphorylation also influences the recruitment of functional surface receptors, with phosphorylation of Nlg-1 at Y782 recruiting cell-surface AMPARs and thus augmenting AMPAR-mediated EPSCs [36]. On the other hand, endogenous Nlg-2 phosphorylation is associated with reductions in spontaneous GABAR-mediated postsynaptic current amplitudes due to reduced GABAR and gephyrin retention at inhibitory synapses [35]. As Nlg phosphorylation is controlled in an activity-dependent fashion, this may represent another distinct mechanism whereby these proteins can dynamically modulate synaptic transmission and plasticity.
Indeed, Nlgs have been found to undergo activity-dependent proteolytic cleavage, which can alter their activity and/or expression. For example, proteolytic cleavage of Nlg-1 prevents its surface expression, leading to the destabilization of trans-synaptic Nrx–Nlg complexes [37][38]. Furthermore, the extracellular fragments of Nlg-1 generated through its proteolytic cleavage can bind to presynaptic metabotropic glutamate receptors, ultimately leading to their activation and the suppression of glutamate release, thereby reducing synaptic strength [39]. Likewise, the induction of Nlg-3 proteolytic cleavage by protein kinase C results in reduced synaptic strength that can be counteracted by the prevention of cleavage. It should be noted that the proteolytic cleavage of Nlg-1 and Nlg-2, indeed, depends on the presence of Nlg-3 through Nlg-1/Nlg-3 or Nlg-2/Nlg-3 heterodimers, indicating the potential role of Nlg-3 as a key regulator of other Nlg cleavage events [40].

2. The Regulators of Neurexin–Neuroligin Interaction

2.1. Hevin

Hevin, also known as SPARC-like protein 1, is a member of the SPARC family that is highly expressed in developing astrocytes, even after reaching adulthood [41]. Structurally, hevin is a cysteine-rich glycoprotein containing a flexible acidic N-terminal region and a globular C-terminal region, which contains a follistatin-like (FS) domain and an extracellular calcium-binding (EC) domain. The FS–EC tandem domains exist as a monomer in solution, maintaining an elongated structure where the FS and EC domains do not interact, suggesting their independent functions. Further studies using surface plasmon resonance have shown that the FS domain contains residues responsible for the hevin–Nlg interaction. It has also been found that the FS domain is sufficient for Nrx binding and that the interaction is calcium-dependent [42].
Interestingly, these structural findings correspond with previous results showing that hevin forms a trans-synaptic bridge between Nrx-1α and Nlg-1, which otherwise do not directly interact with one another under physiological conditions, thus regulating the formation and refinement of thalamocortical glutamatergic synapses [43]. It is found that expression of Nlg-1, PSD-95, homer-1, and the NMDAR subunits are significantly reduced in the cortical postsynaptic membranes of hevin-knockout mice compared with wild-type mice [43]. Of note, in addition to the recruitment of NMDARs, the treatment of cortical neurons with hevin can also raise the number of AMPARs on the cell surface, increasing both the amplitude and frequency of AMPAR-mediated EPSCs [44]. Furthermore, increased co-localization of hevin with the excitatory synaptic markers vesicular glutamate transporter 1, AMPAR subunit, and NMDAR subunit is observed in epileptogenesis, while no co-localization is seen with the inhibitory synaptic markers vesicular GABA transporter and GABAR subunit, suggesting an association of hevin with the modulation of excitatory synapses [45]. Therefore, the trans-synaptic interaction mediated by hevin might be exploited to modulate synaptic reorganization under various neurological conditions via the stabilization of the Nrx–Nlg trans-synaptic bridges.

2.2. SPARC

SPARC, also called osteonectin, is a prototypical member of the SPARC family of biologically active glycoproteins expressed largely in microglia and some subcortical astrocytes in the central nervous system [46]. Examination of the protein structure shows that SPARC is highly homologous to hevin, with three identical structural domains, including the N-terminal, FS, and EC domains [47]. Notably, the SPARC FS domain shares 56% sequence identity with the FS domain of hevin, and they are structurally similar. This intriguing feature suggests that SPARC may interact directly with Nrxs and Nlgs, and, indeed, it has been recently demonstrated that SPARC can bind both Nrxs and Nlgs with a similar affinity as hevin. In particular, SPARC resembles hevin in binding Nlg-2 with comparable affinity and in binding Nrx-1α in a similar calcium-dependent manner, suggesting that it may compete with hevin for binding to both Nrxs and Nlgs [42]. In short, both SPARC and hevin can stabilize the Nrx–Nlg trans-synaptic bridge, and the ratio of SPARC versus hevin regulates Nrx–Nlg interaction and determines the net effect on synaptic function.
It is possible that the actions of one regulator might oppose those of another. Characteristically, SPARC antagonizes the action of hevin in synaptogenesis, with SPARC specifically inhibiting hevin-induced excitatory synaptogenesis; SPARC-null mice show increased synapse formation [47]. Strikingly, SPARC may play multiple roles in synaptic function by regulating the postsynaptic glutamate receptors. During development, SPARC acts more like a “molecular brake” to prevent the over-accumulation of AMPARs, thereby altering both the amplitude and frequency of AMPAR-mediated mEPSCs and decreasing synaptic strength [48]. However, under injury or disease in the mature nervous system, SPARC expression is increased, accompanied by the upregulation of AMPAR substrates at synapses and enhanced synaptic function [49]. Specifically, SPARC treatment reduces the loss of AMPAR subunits in the synapses of hippocampal neurons following oxygen-glucose deprivation, and SPARC may play a novel role in regulating neuronal health and recovery following central nervous system injury. In addition, pretreatment with SPARC is accompanied by a significant increase in synaptic NDMAR subunit levels under the same condition, which could, in turn, enhance synaptic strength and plasticity [49]. Taken together, it is conceivable that SPARC has differential effects on synaptic signaling pathways during development and following injury/disease. It would be important to test the effect of SPARC on the trans-synaptic Nrx–Nlg connection and determine whether this trans-synaptic bridge influences the activities of functional receptors.

2.3. MDGA

MDGAs are vertebrate-specific proteins belonging to the immunoglobulin superfamily and are specifically expressed in the nervous system. The two homologous MDGA proteins, MDGA1 and MDGA2, have a characteristic domain organization composed of an N-terminal signal peptide followed by six immunoglobulin domains, a MAM domain, and a C-terminal domain containing a cleavage site for GPI for anchorage in the cell membrane [50]. Structural determination of the MDGA extracellular region shows a compact, approximately triangular structure that is stabilized by extensive interdomain contacts [51].
Unlike hevin and SPARC, MDGAs interact with Nlgs and, thereby, block sites for Nrx binding, thus suppressing trans-synaptic bridge formation and disrupting synaptic activity [51][52]. The affinity profiles of different MDGAs are Nlg isoform-specific, providing unique modes for regulating different neuronal populations during synaptic development and transmission. Specifically, MDGAs bind in a cis configuration with a lower affinity to Nlg-3 and Nlg-4 than to Nlg-1 and Nlg-2. In addition, MDGA1 selectively forms complexes with Nlg-2, and MDGA2 selectively forms complexes with Nlg-1 [53]. Analysis of mouse mutants shows that targeted mutations of MDGA1 and MDGA2 promote the activities of inhibitory and excitatory synapses, respectively, suggesting functional divergence between the proteins [51]. In line with this notion, RNAi-mediated knockdown of MDGA1 increases the number of inhibitory synapses in cultured rat hippocampal neurons without affecting the number of excitatory synapses [54]. Mutation of MDGA2 increases excitatory synapse numbers and elevates excitatory transmission by blocking Nlg-1 interaction with Nrxs, with no influence on inhibitory synapses [55]. Intriguingly, MDGAs and hevin compete for the same Nlg binding sites and such competition may shape the excitatory and inhibitory balance mediated by molecular crosstalk between different modifiers of the Nrx–Nlg interaction [42]. Thus, examining how different MDGAs modulate Nrx–Nlg interaction will enhance our understanding of the mechanisms underlying synapse plasticity and provide new insights into the etiology of neurological disorders.


  1. Lin, T.B.; Lai, C.Y.; Hsieh, M.C.; Jiang, J.L.; Cheng, J.K.; Chau, Y.P.; Ruan, T.; Chen, G.D.; Peng, H.Y. Neuropathic allodynia involves spinal neurexin-1β-dependent neuroligin-1/postsynaptic density-95/NR2B cascade in rats. Anesthesiology 2015, 123, 909–926.
  2. Graf, E.R.; Zhang, X.; Jin, S.X.; Linhoff, M.W.; Craig, A.M. Neurexins induce differentiation of GABA and glutamate postsynaptic specializations via neuroligins. Cell 2004, 119, 1013–1026.
  3. Südhof, T.C. Towards an Understanding of Synapse Formation. Neuron 2018, 100, 276–293.
  4. Luo, F.; Sclip, A.; Merrill, S.; Südhof, T.C. Neurexins regulate presynaptic GABAB-receptors at central synapses. Nat. Commun. 2021, 12, 2380.
  5. Roberts, B.M.; Lopes, E.F.; Cragg, S.J. Axonal modulation of striatal dopamine release by local γ-aminobutyric acid (GABA) signalling. Cells 2021, 10, 709.
  6. Luo, F.; Sclip, A.; Jiang, M.; Südhof, T.C. Neurexins cluster Ca2+ channels within the presynaptic active zone. EMBO J. 2020, 39, e103208.
  7. Sánchez-Hidalgo, A.C.; Arias-Aragón, F.; Romero-Barragán, M.T.; Martín-Cuevas, C.; Delgado-García, J.M.; Martinez-Mir, A.; Scholl, F.G. Selective expression of the neurexin substrate for presenilin in the adult forebrain causes deficits in associative memory and presynaptic plasticity. Exp. Neurol. 2022, 347, 113896.
  8. Anderson, G.R.; Aoto, J.; Tabuchi, K.; Földy, C.; Covy, J.; Yee, A.X.; Wu, D.; Lee, S.J.; Chen, L.; Malenka, R.C.; et al. β-neurexins control neural circuits by regulating synaptic endocannabinoid signaling. Cell 2015, 162, 593–606.
  9. Aoto, J.; Martinelli, D.C.; Malenka, R.C.; Tabuchi, K.; Südhof, T.C. Presynaptic neurexin-3 alternative splicing trans-synaptically controls postsynaptic AMPA receptor trafficking. Cell 2013, 154, 75–88.
  10. Dai, J.; Aoto, J.; Südhof, T.C. Alternative splicing of presynaptic neurexins differentially controls postsynaptic NMDA and AMPA receptor responses. Neuron 2019, 102, 993–1008.e5.
  11. Miyazaki, T.; Morimoto-Tomita, M.; Berthoux, C.; Konno, K.; Noam, Y.; Yamasaki, T.; Verhage, M.; Castillo, P.E.; Watanabe, M.; Tomita, S. Excitatory and inhibitory receptors utilize distinct post- and trans-synaptic mechanisms in vivo. Elife 2021, 10, e59613.
  12. Boxer, E.E.; Seng, C.; Lukacsovich, D.; Kim, J.; Schwartz, S.; Kennedy, M.J.; Földy, C.; Aoto, J. Neurexin-3 defines synapse- and sex-dependent diversity of GABAergic inhibition in ventral subiculum. Cell Rep. 2021, 37, 110098.
  13. Sato, Y.; Iijima, Y.; Darwish, M.; Sato, T.; Iijima, T. Distinct expression of SLM2 underlies splicing-dependent trans-synaptic signaling of neurexin across GABAergic neuron subtypes. Neurochem. Res. 2021, in press.
  14. Trotter, J.H.; Hao, J.; Maxeiner, S.; Tsetsenis, T.; Liu, Z.; Zhuang, X.; Südhof, T.C. Synaptic neurexin-1 assembles into dynamically regulated active zone nanoclusters. J. Cell Biol. 2019, 218, 2677–2698.
  15. Klatt, O.; Repetto, D.; Brockhaus, J.; Reissner, C.; El Khallouqi, A.; Rohlmann, A.; Heine, M.; Missler, M. Endogenous β-neurexins on axons and within synapses show regulated dynamic behavior. Cell Rep. 2021, 35, 109266.
  16. Saura, C.A.; Servián-Morilla, E.; Scholl, F.G. Presenilin/γ-secretase regulates neurexin processing at synapses. PLoS ONE 2011, 6, e19430.
  17. Zhang, P.; Lu, H.; Peixoto, R.T.; Pines, M.K.; Ge, Y.; Oku, S.; Siddiqui, T.J.; Xie, Y.; Wu, W.; Archer-Hartmann, S.; et al. Heparan sulfate organizes neuronal synapses through neurexin partnerships. Cell 2018, 174, 1450–1464.e23.
  18. Hu, X.; Luo, J.H.; Xu, J. The interplay between synaptic activity and neuroligin function in the CNS. Biomed. Res. Int. 2015, 2015, 498957.
  19. Varoqueaux, F.; Aramuni, G.; Rawson, R.L.; Mohrmann, R.; Missler, M.; Gottmann, K.; Zhang, W.; Südhof, T.C.; Brose, N. Neuroligins determine synapse maturation and function. Neuron 2006, 51, 741–754.
  20. Taylor, S.C.; Ferri, S.L.; Grewal, M.; Smernoff, Z.; Bucan, M.; Weiner, J.A.; Abel, T.; Brodkin, E.S. The role of synaptic cell adhesion molecules and associated scaffolding proteins in social affiliative behaviors. Biol. Psychiatry 2020, 88, 442–451.
  21. Bemben, M.A.; Shipman, S.L.; Nicoll, R.A.; Roche, K.W. The cellular and molecular landscape of neuroligins. Trends Neurosci. 2015, 38, 496–505.
  22. Prange, O.; Wong, T.P.; Gerrow, K.; Wang, Y.T.; El-Husseini, A. A balance between excitatory and inhibitory synapses is controlled by PSD-95 and neuroligin. Proc. Natl. Acad. Sci. USA 2004, 101, 13915–13920.
  23. Ali, H.; Marth, L.; Krueger-Burg, D. Neuroligin-2 as a central organizer of inhibitory synapses in health and disease. Sci. Signal. 2020, 13, eabd8379.
  24. Chubykin, A.A.; Atasoy, D.; Etherton, M.R.; Brose, N.; Kavalali, E.T.; Gibson, J.R.; Südhof, T.C. Activity-dependent validation of excitatory versus inhibitory synapses by neuroligin-1 versus neuroligin-2. Neuron 2007, 54, 919–931.
  25. Chubykin, A.A.; Atasoy, D.; Etherton, M.R.; Brose, N.; Kavalali, E.T.; Gibson, J.R.; Südhof, T.C. Neuroligin-1 controls synaptic abundance of NMDA-type glutamate receptors through extracellular coupling. Proc. Natl. Acad. Sci. USA 2013, 110, 725–730.
  26. Jiang, M.; Polepalli, J.; Chen, L.Y.; Zhang, B.; Südhof, T.C.; Malenka, R.C. Conditional ablation of neuroligin-1 in CA1 pyramidal neurons blocks LTP by a cell-autonomous NMDA receptor-independent mechanism. Mol. Psychiatry 2017, 22, 375–383.
  27. Wu, X.; Morishita, W.K.; Riley, A.M.; Hale, W.D.; Südhof, T.C.; Malenka, R.C. Neuroligin-1 signaling controls LTP and NMDA receptors by distinct molecular pathways. Neuron 2019, 102, 621–635.e3.
  28. Hines, R.M.; Wu, L.; Hines, D.J.; Steenland, H.; Mansour, S.; Dahlhaus, R.; Singaraja, R.R.; Cao, X.; Sammler, E.; Hormuzdi, S.G.; et al. Synaptic imbalance, stereotypies, and impaired social interactions in mice with altered neuroligin 2 expression. J. Neurosci. 2008, 28, 6055–6067.
  29. Troyano-Rodriguez, E.; Wirsig-Wiechmann, C.R.; Ahmad, M. Neuroligin-2 determines inhibitory synaptic transmission in the lateral septum to optimize stress-induced neuronal activation and avoidance behavior. Biol. Psychiatry 2019, 85, 1046–1055.
  30. Uchigashima, M.; Konno, K.; Demchak, E.; Cheung, A.; Watanabe, T.; Keener, D.G.; Abe, M.; Le, T.; Sakimura, K.; Sasaoka, T.; et al. Specific Neuroligin3-αNeurexin1 signaling regulates GABAergic synaptic function in mouse hippocampus. Elife 2020, 9, e59545.
  31. Uchigashima, M.; Leung, M.; Watanabe, T.; Cheung, A.; Le, T.; Pallat, S.; Dinis, A.L.M.; Watanabe, M.; Kawasawa, Y.I.; Futai, K. Neuroligin3 splice isoforms shape inhibitory synaptic function in the mouse hippocampus. J. Biol. Chem. 2020, 295, 8589–8595.
  32. Bemben, M.A.; Shipman, S.L.; Hirai, T.; Herring, B.E.; Li, Y.; Badger, J.D.; Nicoll, R.A.; Diamond, J.S.; Roche, K.W. CaMKII phosphorylation of neuroligin-1 regulates excitatory synapses. Nat. Neurosci. 2014, 7, 56–64.
  33. Jeong, J.; Pandey, S.; Li, Y.; Badger, J.D.; Lu, W.; Roche, K.W. PSD-95 binding dynamically regulates NLGN1 trafficking and function. Proc. Natl. Acad. Sci. USA 2019, 116, 12035–12044.
  34. Letellier, M.; Szíber, Z.; Chamma, I.; Saphy, C.; Papasideri, I.; Tessier, B.; Sainlos, M.; Czöndör, K.; Thoumine, O. A unique intracellular tyrosine in neuroligin-1 regulates AMPA receptor recruitment during synapse differentiation and potentiation. Nat. Commun. 2018, 9, 3979.
  35. Antonelli, R.; Pizzarelli, R.; Pedroni, A.; Fritschy, J.M.; Del-Sal, G.; Cherubini, E.; Zacchi, P. Pin1-dependent signalling negatively affects GABAergic transmission by modulating neuroligin2/gephyrin interaction. Nat. Commun. 2014, 5, 5066.
  36. Letellier, M.; Lagardère, M.; Tessier, B.; Janovjak, H.; Thoumine, O. Optogenetic control of excitatory post-synaptic differentiation through neuroligin-1 tyrosine phosphorylation. Elife 2020, 9, e52027.
  37. Suzuki, K.; Hayashi, Y.; Nakahara, S.; Kumazaki, H.; Prox, J.; Horiuchi, K.; Zeng, M.; Tanimura, S.; Nishiyama, Y.; Osawa, S.; et al. Activity-dependent proteolytic cleavage of neuroligin-1. Neuron 2012, 76, 410–422.
  38. Peixoto, R.T.; Kunz, P.A.; Kwon, H.; Mabb, A.M.; Sabatini, B.L.; Philpot, B.D.; Ehlers, M.D. Transsynaptic signaling by activity-dependent cleavage of neuroligin-1. Neuron 2012, 76, 396–409.
  39. Gjørlund, M.D.; Carlsen, E.M.M.; Kønig, A.B.; Dmytrieva, O.; Petersen, A.V.; Jacobsen, J.; Berezin, V.; Perrier, J.F.; Owczarek, S. Soluble ectodomain of neuroligin 1 decreases synaptic activity by activating metabotropic glutamate receptor 2. Front. Mol. Neurosci. 2017, 10, 116.
  40. Bemben, M.A.; Nguyen, T.A.; Li, Y.; Wang, T.; Nicoll, R.A.; Roche, K.W. Isoform-specific cleavage of neuroligin-3 reduces synapse strength. Mol. Psychiatry 2019, 24, 145–160.
  41. Murphy-Ullrich, J.E.; Sage, E.H. Revisiting the matricellular concept. Matrix Biol. 2014, 37, 1–14.
  42. Fan, S.; Gangwar, S.P.; Machius, M.; Rudenko, G. Interplay between hevin, SPARC, and MDGAs: Modulators of neurexin-neuroligin transsynaptic bridges. Structure 2021, 29, 664–678.e6.
  43. Singh, S.K.; Stogsdill, J.A.; Pulimood, N.S.; Dingsdale, H.; Kim, Y.H.; Pilaz, L.J.; Kim, I.H.; Manhaes, A.C.; Rodrigues, W.S., Jr.; Pamukcu, A.; et al. Astrocytes assemble thalamocortical synapses by bridging NRX1α and NL1 via hevin. Cell 2016, 164, 183–196.
  44. Kim, J.H.; Jung, H.G.; Kim, A.; Shim, H.S.; Hyeon, S.J.; Lee, Y.S.; Han, J.; Jung, J.H.; Lee, J.; Ryu, H.; et al. Hevin-calcyon interaction promotes synaptic reorganization after brain injury. Cell Death Differ. 2021, 28, 2571–2588.
  45. Lively, S.; Brown, I.R. The extracellular matrix protein SC1/hevin localizes to excitatory synapses following status epilepticus in the rat lithium-pilocarpine seizure model. J. Neurosci. Res. 2008, 86, 2895–2905.
  46. Vincent, A.J.; Lau, P.W.; Roskams, A.J. SPARC is expressed by macroglia and microglia in the developing and mature nervous system. Dev. Dyn. 2008, 237, 1449–1462.
  47. Kucukdereli, H.; Allen, N.J.; Lee, A.T.; Feng, A.; Ozlu, M.I.; Conatser, L.M.; Chakraborty, C.; Workman, G.; Weaver, M.; Sage, E.H.; et al. Control of excitatory CNS synaptogenesis by astrocyte-secreted proteins Hevin and SPARC. Proc. Natl. Acad. Sci. USA 2011, 108, E440–E449.
  48. Jones, E.V.; Bernardinelli, Y.; Tse, Y.C.; Chierzi, S.; Wong, T.P.; Murai, K.K. Astrocytes control glutamate receptor levels at developing synapses through SPARC-beta-integrin interactions. J. Neurosci. 2011, 31, 4154–4165.
  49. Jones, E.V.; Bernardinelli, Y.; Zarruk, J.G.; Chierzi, S.; Murai, K.K. SPARC and GluA1-containing AMPA receptors promote neuronal health following CNS injury. Front. Cell Neurosci. 2018, 12, 22.
  50. Litwack, E.D.; Babey, R.; Buser, R.; Gesemann, M.; O’Leary, D.D. Identification and characterization of two novel brain-derived immunoglobulin superfamily members with a unique structural organization. Mol. Cell. Neurosci. 2004, 25, 263–274.
  51. Connor, S.A.; Elegheert, J.; Xie, Y.; Craig, A.M. Pumping the brakes: Suppression of synapse development by MDGA-neuroligin interactions. Curr. Opin. Neurobiol. 2019, 57, 71–80.
  52. Kim, J.A.; Kim, D.; Won, S.Y.; Han, K.A.; Park, D.; Cho, E.; Yun, N.; An, H.J.; Um, J.W.; Kim, E.; et al. Structural insights into modulation of neurexin-neuroligin trans-synaptic adhesion by MDGA1/neuroligin-2 complex. Neuron 2017, 94, 1121–1131.e6.
  53. Elegheert, J.; Cvetkovska, V.; Clayton, A.J.; Heroven, C.; Vennekens, K.M.; Smukowski, S.N.; Regan, M.C.; Jia, W.; Smith, A.C.; Furukawa, H.; et al. Structural mechanism for modulation of synaptic neuroligin-neurexin signaling by MDGA proteins. Neuron 2021, 109, 189–190.
  54. Lee, K.; Kim, Y.; Lee, S.J.; Qiang, Y.; Lee, D.; Lee, H.W.; Kim, H.; Je, H.S.; Südhof, T.C.; Ko, J. MDGAs interact selectively with neuroligin-2 but not other neuroligins to regulate inhibitory synapse development. Proc. Natl. Acad. Sci. USA 2013, 110, 336–341.
  55. Connor, S.A.; Ammendrup-Johnsen, I.; Chan, A.W.; Kishimoto, Y.; Murayama, C.; Kurihara, N.; Tada, A.; Ge, Y.; Lu, H.; Yan, R.; et al. Altered cortical dynamics and cognitive function upon haploinsufficiency of the autism-linked excitatory synaptic suppressor MDGA2. Neuron 2016, 91, 1052–1068.
Contributors MDPI registered users' name will be linked to their SciProfiles pages. To register with us, please refer to : , , , ,
View Times: 487
Entry Collection: Neurodegeneration
Revisions: 2 times (View History)
Update Date: 01 Jul 2022